A. Katz

发表

Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases.

M. Schell, A. Muhs, P. Okunieff, 2007, International journal of radiation oncology, biology, physics.

High dose rate brachytherapy for nonmalignant airway obstruction: new treatment option.

M. Kramer, R. Feinmesser, A. Sulkes, 2003, Chest.

Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy.

M. Schell, Yuhchyau Chen, P. Okunieff, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver Metastases.

M. Schell, C. Willett, L. Dawson, 2019, Practical radiation oncology.

Curcumin for Radiation Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Thirty Breast Cancer Patients

C. Heckler, M. Ling, Jacqueline P. Williams, 2013, Radiation research.

Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel.

M. Lapidoth, A. Sulkes, A. Katz, 1998, American journal of clinical oncology.

Five-year Biochemical Control Rates for Stereotactic Body Radiation Therapy for Organ-confined Prostate Cancer: A Multi-institutional Pooled Analysis

R. Meier, J. Aronovitz, C. King, 2012 .

Can Surgery be Avoided After Preoperative Chemoradiation for Rectal Cancer in the Era of Organ Preservation? Current Review of Literature

J. Monson, A. Katz, S. Rauh, 2015, American journal of clinical oncology.

Short course radiation therapy for rectal cancer in the elderly: can radical surgery be avoided?

M. Tejani, F. Fleming, K. Usuki, 2019, Journal of gastrointestinal oncology.

Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy.

M. Schell, P. Okunieff, M. Milano, 2008, International journal of radiation oncology, biology, physics.

Expected PSA and Biochemical Control with Prostate SBRT Compared to Conventional Fractionated Radiotherapy

A. Katz, Josephine Kang, 2018, Stereotactic Radiosurgery for Prostate Cancer.

Hypersensitivity Reaction to Cisplatin During Chemoradiation Therapy for Gynecologic Malignancy

R. Yerushalmi, A. Sulkes, A. Katz, 2002, American journal of clinical oncology.

Hypofractionated Stereotactic Radiotherapy for Non-breast or Prostate Cancer Oligometastases: A Tail of Survival Beyond 10 Years

Deepinder P. Singh, P. Okunieff, M. Milano, 2019, Front. Oncol..

Hypofractionated Stereotactic Body Radiation Therapy for Liver Metastases

M. Schell, A. Muhs, P. Okunieff, 2005 .

Stereotactic Body Radiation Therapy (SBRT) for lung metastases

Abraham Philip, M. Schell, P. Okunieff, 2006, Acta oncologica.

Stereotactic body radiation therapy versus metastasectomy for oligometastases.

M. Milano, A. Katz, H. Qiu, 2019, Journal of thoracic disease.

Case Report: Umbilical Metastases of Gallbladder Carcinoma Unrelated to a Laparoscopic Procedure

A. Figer, A. Sulkes, A. Katz, 2000, Digestive Diseases and Sciences.

Successful use of high dose rate brachytherapy for non-malignant bronchial obstruction

M. Kramer, D. Schifter, A. Katz, 2001, Thorax.

Role of radiation therapy in the management of cutaneous malignant melanoma.

H. Gutman, A. Sulkes, A. Katz, 1999, American journal of clinical oncology.

Hypofractionated Stereotactic Radiation Therapy for Metastatic Adenocarcinoma ex Goblet Cell Carcinoid of the Appendix: Case Report and Literature Review

A. Katz, J. W. Clyde, 2019, Case Reports in Oncology.

Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and Patterns of Failure

S. Formenti, A. Katz, Josephine Kang, 2016, Front. Oncol..

Solitary metastases: illusion versus reality.

R. Brasacchio, P. Rubin, A. Katz, 2006, Seminars in radiation oncology.

Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010.

D. Wigle, T. Dipetrillo, L. Kachnic, 2020 .

Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study.

P. Okunieff, Hong Zhang, M. Milano, 2012, International journal of radiation oncology, biology, physics.

Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival

Deepinder P. Singh, Yuhchyau Chen, P. Okunieff, 2015, American journal of clinical oncology.

Oligometastases to the liver: predicting outcomes based upon radiation sensitivity.

M. Milano, A. Katz, H. Qiu, 2016, Journal of thoracic disease.

Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer

J. Sulkes, A. Sulkes, A. Katz, 2001, International Journal of Gynecologic Cancer.

The role of radiation therapy and chemotherapy in the treatment of merkel cell carcinoma

A. Sulkes, A. Katz, B. Brenner, 1997, Cancer.

Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposide.

J. Schachter, A. Sulkes, A. Katz, 2000, American journal of clinical oncology.

2191 The role of radiotherapy and chemotherapy in the treatment of Merkel cell carcinoma

A. Sulkes, A. Katz, B. Brenner, 1996 .

Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research

C. Heckler, S. Mohile, Jacqueline P. Williams, 2012, Supportive Care in Cancer.

Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial

D. Wigle, T. Dipetrillo, L. Kachnic, 2022, The Lancet Oncology.

A prospective pilot study of curative‐intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions

M. Schell, A. Muhs, P. Okunieff, 2008, Cancer.

Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question—Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head

R. Abrams, B. Fisher, P. Philip, 2020, American journal of clinical oncology.

Unresectable locally advanced pancreatic cancer: treatment with neoadjuvant leucovorin, fluorouracil, irinotecan, and oxaliplatin and assessment of surgical resectability.

A. Hezel, A. Katz, M. Noel, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade.

P. Okunieff, Hong Zhang, M. Milano, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy

K. Usuki, M. Milano, A. Katz, 2018, American journal of clinical oncology.

Stereotactic body radiotherapy for treatment of adrenal metastases.

A. Muhs, Yuhchyau Chen, P. Okunieff, 2009, International journal of radiation oncology, biology, physics.

Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors

Charles M. Miller, J. Sanabria, K. Goodman, 2012, Acta oncologica.

Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation.

A. Hezel, M. Milano, A. Katz, 2012, International journal of radiation oncology, biology, physics.

SBRT for Hepatocellular Carcinoma: 8-Year Experience from a Regional Transplant Center

K. Usuki, M. Milano, A. Katz, 2018, Journal of Gastrointestinal Cancer.

Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge?

L. Constine, A. Katz, Madeleine Carey Sampson, 2006, Seminars in radiation oncology.

Stereotactic body radiotherapy with or without external beam radiation as treatment for organ confined high-risk prostate carcinoma: a six year study

A. Katz, Josephine Kang, Josephine Kang, 2014, Radiation Oncology.

Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines.

H. Gutman, J. Schacter, A. Sulkes, 1999, International journal of oncology.

Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting.

Niko Papanikolaou, Daniel T Chang, Clifton D Fuller, 2011, International journal of radiation oncology, biology, physics.

Multicentre results of stereotactic body radiotherapy for secondary liver tumours.

Charles M. Miller, J. Sanabria, K. Goodman, 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Results of the randomized phase II portion of NRG Oncology/RTOG 0848 evaluating the addition of erlotinib to adjuvant gemcitabine for patients with resected pancreatic head adenocarcinoma.

R. Abrams, B. Fisher, P. Philip, 2017 .

Long term Outcomes of NRG Oncology/RTOG 0529: A Phase II Evaluation of Dose-Painted Intensity Modulated Radiation Therapy (DP-IMRT) in Combination with 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer.

B. Fisher, L. Kachnic, T. Schefter, 2021, International journal of radiation oncology, biology, physics.

Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial.

H. Gutman, J. Schachter, J. Sulkes, 2001, Oncology reports.

Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma

A. Hezel, M. Tejani, M. Orloff, 2015, Advances in radiation oncology.

Stereotactic body radiotherapy for prostate cancer: ready for prime time?

A. Katz, 2012, Journal of Radiation Oncology.

Modulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy

S. Gerber, M. Drage, D. Linehan, 2021, Clinical Cancer Research.

Hypo-fractionated SBRT for localized prostate cancer: a German bi-center single treatment group feasibility trial

A. Ziegler, K. Jünemann, J. Dunst, 2017, Radiation oncology.

Stereotactic Body Radiation Therapy for Low-, Intermediate-, and High-Risk Prostate Cancer: Disease Control and Quality of Life at 6 Years

J. Kang, A. Katz, 2013 .

Patterns of Recurrence After Curative-Intent Radiation for Oligometastases Confined to One Organ

P. Okunieff, M. Milano, A. Katz, 2009, American journal of clinical oncology.

Patterns and Yearly Time Trends in the Use of Radiation Therapy During the Last 30 Days of Life Among Patients With Metastatic Rectal Cancer in the United States From 2004 to 2012

J. Monson, K. Noyes, F. Fleming, 2018, The American journal of hospice & palliative care.

Stereotactic Body Radiation Therapy as a Bridge to Transplantation and for Recurrent Disease in the Transplanted Liver of a Patient with Hepatocellular Carcinoma

A. Hezel, A. Katz, A. Mazloom, 2014, Case Reports in Oncology.

Merkel cell carcinoma in Israel.

M. Feinmesser, E. Rakowski, A. Sulkes, 1996, Israel journal of medical sciences.

Stereotactic Body Radiation Therapy for Oligometastatic Renal Cell Carcinoma or Melanoma: Prognostic Factors and Outcomes

Deepinder P. Singh, R. Brasacchio, Yuhchyau Chen, 2015 .

High dose rate brachytherapy for nonmalignant airway obstruction: new treatment option.

M. Kramer, R. Feinmesser, A. Sulkes, 2003, Chest.

Stereotactic body radiotherapy for treatment of adrenal metastases.

A. Muhs, Yuhchyau Chen, P. Okunieff, 2009, International journal of radiation oncology, biology, physics.